Visiongain Launches Report Examining the Potential in the $118bn Translational Regenerative Medicine Market – PR Newswire UK

- Translational Regenerative Medicine Market Forecast 2020-2030

- Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

LONDON, March 6, 2020 /PRNewswire/ -- The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 24% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 59% in 2019.

How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report you will find338-page reportand you will receive116 tables, 104 figures and 3 interviews all unavailable elsewhere.

The 338-page Visiongain report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.comor refer to our website: https://www.visiongain.com/report/translational-regenerative-medicine-market-forecast-2020-2030/#download_sampe_div

Report Scope

Global Translational Regenerative Medicine market forecastsfrom 2020-2030

Global Translational Regenerative Medicinesubmarket forecastsfrom 2020-2030 covering: Stem Cell Therapies Tissue Engineered Products Gene Therapies

This study discusses thelate-stage clinical trialsandpipelineas well asmarket driversandrestraintsof each submarket.

Translational Regenerative Medicineregional and nationalmarket forecastsfrom 2020-2030, covering: North America:US, Canada Europe:Germany, France, UK, Italy, Spain, Rest of Europe Asia-Pacific:China, Japan, India, Rest of Asia-Pacific Latin America:Brazil, Mexico, Rest of Latin America Middle East & Africa:GCC Countries, South Africa, Rest of Middle East & Africa

Each regional market is further segmented by sector.

Forecasts from 2020-2030 of the selectedleading productsin the Global Translational Regenerative Medicine market: Osteocel Plus Trinity ELITE TEMCELL /Prochymal Apligraf Dermagraft Epifix ReCell Neovasculgen IMLYGIC (talimogene laherparepvec)

Assessment of theleading companiesin the Global Translational Regenerative Medicine market: Astellas Pharma Athersys Avita Medical AxoGen, Inc. MEDIPOST Co., Ltd. NuVasive Organogenesis Holdings, Inc. Osiris Therapeutics, Inc. Pharmicell Co., Ltd. Takeda uniQure N.V. Vericell Corporation

Information oncurrent developments, current advancementsandcurrent key approvalsin the field of translational regenerative medicine market.

SWOTandPorter's Five Force analysisof the translational regenerative medicine market

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.comor refer to our website: https://www.visiongain.com/report/translational-regenerative-medicine-market-forecast-2020-2030/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.comto discuss any customized research needs you may have.

Companies covered in the report include:

Aastrom Biosciences, Inc.Abeona Therapeutics Inc.AdvantageneAgeless Regenerative InstituteAlliqua BioMedical, Inc.AlloSourceAlphaTecSpineAltrikaAndalusian Initiative for Advanced Therapies - Fundacin Pblica Andaluza Progreso y SaludAnGes MG/VicalAnterogenArizona Pain SpecialistsAssistance Publique Hopitaux De MarseilleAstellas PharmaAthersys, Inc.Avita MedicalAxiogenesis AGAxoGen, Inc.BaxterBellicum PharmaceuticalsBenda PharmaceuticalBiedermann Technologies GmbH & Co. KGBioCardia, Inc.Bioheartbluebird bioBrainStorm Cell TherapeuticsBristol-Meyers SquibbCaladrius BiosciencesCapricorCardio3 BioSciencesCelgeneCell MedicaCellerant TherapeuticsCellular Dynamics International, Inc.CeregeneChiesi Farmaceutici SpACold GenesysCytori TherapeuticsDePuy MitekDimension Therapeutics, Inc.Fibrocell ScienceFUJIFILM CorporationGE HealthcareGenzymeHealeon Medical IncHEALIOS K.K.HemostemixHoffmann-La RocheHomology Medicines, Inc.Innovative Cellular Therapeutics (ICT)Integra LifeSciencesIntrexonInvetechIrvine ScientificJapan Regenerative Medicine Co., Ltd.Japan Tissue Engineering Co. LtdJCR Pharmaceuticals Co. Ltd.Jianwu DaiJohnson & JohnsonKinetic Concepts IncKite PharmaLonza Houston, Inc.MacroCureMedipostMediStemMedtronicMesoblast, Ltd.MidCap Financial Services (MidCap Financial)MiMedx Group, Inc.Nasser Aghdami MD., PhDNovartisNuVasiveOcata TherapeuticsOhioHealthOrchard TherapeuticsOrganogenesis Holdings Inc.OrthofixOsiris Therapeutics, Inc.Oxford BioMedicaPall CorporationParcell LaboratoriesPfizer, Inc.PharmaceuticalPharmicell Co., Ltd.Promethera Biosciences SARegen Lab SARegenerative Patch Technologies, LLCRegenerative Sciences, LLCRegenerys Ltd.RegeneusReNeuronRoyan InstituteSangamo BioSciencesSanofiSemma TherapeuticsServierShanghai SunwayShinya YamanakaSiemens HealthineersSilicon Valley BankSkye OrthobiologicsSobi PartnersSotex PharmFirmSpark TherapeuticsStemCells Inc.Stempeutics ResearchTakeda PharmaceuticalsTiGenixTissueGene, Inc.U.S. Stem Cell Inc.uniQure NVUniversal Cells, Inc.Vericell CorporationViaCyte IncXenetic BiosciencesZimmer

List of Organisations Mentioned in This ReportAcademy Military Medical Science, ChinaAmerican Diabetes AssociationAndalusian Initiative for Advanced TherapiesArthritis Research UKAustralian Regenerative Medicine InstituteAustralian Research CouncilBanc de Sang i TeixitsBeijing Cancer HospitalBrazil Ministry of Health, Ministry of EducationBrazilian Development Bank (BNDES)British Heart FoundationCambridge University Hospitals NHS Foundation TrustCatalan Institution for Research and Advanced StudiesCenter for Biologics Evaluation and Research (CBER)Center for Devices and Radiological Health (CDRH).Center for Drug Evaluation and Research (CDER)Centre Hospitalier Ren DubosCharit University ClinicChina Construction bankChinese Academy of SciencesCommittee for Advanced TherapiesCommittee for Medicinal Products for Human Use (CHMP)Department of Health and the Care Quality CommissionDrugs Controller General of IndiaEuropean CommissionEuropean Group for Blood and Marrow TransplantationEuropean Medicines AgencyEuropean Patent OfficeEuropean UnionFood and Drug Administration (FDA)Fourth Military Medical UniversityGerman National Registry of Blood Stem Cell DonorsHerlev HospitalHouse of Lords Science and Technology CommitteeHuman Fertilisation and Embryology AuthorityHuman Stem Cell InstituteInnovation in JapanInstitute for Biomedical ResearchKenneth HargreavesKing Abdullah International Medical Research Centre (KAIMRC)King Khaled UniversityKing Saud bin Abdulaziz University for Health Sciences (KSAU - HS)Korea Food and Drug AdministrationKuopio University HospitalMassachusetts General Hospital (MGH)Medical Research CouncilMinistry of Food and Drug SafetyMinistry of Public Health, Republic of BelarusMusculoskeletal Transplant Foundation (MTF)Northwestern UniversityNursing Association for the Study of Cutaneous WoundsOregon Health and Science UniversityPharmaceuticals and Medical Devices Agency (PMDA)Regenerative Medicines in Europe Project (REMEDiE)Russian Academy of Medical SciencesRussian Ministry of Healthcare and Social DevelopmentServizio Sanitario Nazionale, ItalySidney Kimmel Comprehensive Cancer CenterSouth African GovernmentSouth China Research Center for Stem Cell and Regenerative MedicineStanford UniversityState Food and Drug AdministrationThe University of Texas Health Science Center, HoustonTherapeutics Goods AdministrationUniversity College LondonUniversity Hospital of Basel, SwitzerlandUniversity of California, Los Angeles (UCLA)University of California, San Francisco (UCSF)University of LeedsUniversity of MassachusettsWenzhou Medical UniversityWorld BankYamaguchi University Hospital

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Global Stem Cell Technologies and Applications Market 2019-2029

Biobanking Market Forecasts 2019-2029

Global Precision Medicine Market Forecast 2019-2029

Global Rare Disease Drugs Market Forecast 2019-2029

Global Bioreactors Market 2020-2030

Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

SOURCE Visiongain

See the rest here:
Visiongain Launches Report Examining the Potential in the $118bn Translational Regenerative Medicine Market - PR Newswire UK

Related Posts